Patents by Inventor Iker NAVARRO

Iker NAVARRO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of portal hypertension and cirrhosis
    Patent number: 11883400
    Abstract: Methods and formulations are provided for the treatment and prevention of portal hypertension.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: January 30, 2024
    Assignee: Noorik Biopharmaceuticals AG
    Inventor: Iker Navarro
  • AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
    Publication number: 20230233454
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Application
    Filed: March 31, 2023
    Publication date: July 27, 2023
    Applicant: Noorik Biopharmaceuticals AG
    Inventors: Iker Navarro, Satish KHANNA
  • Ambrisentan for use in the treatment of acute renal failure
    Patent number: 11642307
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: May 9, 2023
    Assignee: Noorik Biopharmaceuticals AG
    Inventor: Iker Navarro
  • TREATMENT OF PORTAL HYPERTENSION AND CIRRHOSIS
    Publication number: 20210338667
    Abstract: Methods and formulations are provided for the treatment and prevention of portal hypertension.
    Type: Application
    Filed: October 21, 2019
    Publication date: November 4, 2021
    Applicant: Noorik Biopharmaceuticals AG
    Inventor: Iker NAVARRO
  • AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
    Publication number: 20210046332
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 18, 2021
    Applicant: Noorik Biopharmaceuticals AG
    Inventors: Iker NAVARRO, Satish KHANNA
  • Ambrisentan for use in the treatment of acute renal failure
    Patent number: 10870021
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: December 22, 2020
    Assignee: NOORIK BIOPHARMACEUTICALS AG
    Inventors: Iker Navarro, Satish Khanna
  • AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
    Publication number: 20190083820
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Application
    Filed: March 20, 2017
    Publication date: March 21, 2019
    Applicant: Noorik Biopharmaceuticals AG
    Inventors: Iker NAVARRO, Satish KHANNA